This was the stock's fourth consecutive day of gains.

With a rising number of pet owners and increased spending, the pet industry is demonstrating strong growth potential.

Butter themed license plates? Listeria outbreak in nursing homes? $20M in frozen farmer funds released? Check out these ...

A perfect example of this combination today is animal healthcare specialist Zoetis (NYSE: ZTS). Whether helping our furry ...

This was the stock's third consecutive day of gains.

The US Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry.

Greenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 ...

BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The ...